DK3148576T3 - Vaccinesammensætning mod streptococcus suis-infektion - Google Patents

Vaccinesammensætning mod streptococcus suis-infektion Download PDF

Info

Publication number
DK3148576T3
DK3148576T3 DK15726586.9T DK15726586T DK3148576T3 DK 3148576 T3 DK3148576 T3 DK 3148576T3 DK 15726586 T DK15726586 T DK 15726586T DK 3148576 T3 DK3148576 T3 DK 3148576T3
Authority
DK
Denmark
Prior art keywords
vaccine composition
streptococcus suis
composition against
against streptococcus
suis infection
Prior art date
Application number
DK15726586.9T
Other languages
English (en)
Inventor
Jana Seele
Christoph Baums
Peter Valentin-Weigand
Original Assignee
Ceva Sante Animale S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50846835&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3148576(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ceva Sante Animale S A filed Critical Ceva Sante Animale S A
Application granted granted Critical
Publication of DK3148576T3 publication Critical patent/DK3148576T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
DK15726586.9T 2014-05-30 2015-05-29 Vaccinesammensætning mod streptococcus suis-infektion DK3148576T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14170637.4A EP2949340A1 (en) 2014-05-30 2014-05-30 Vaccine composition against Streptococcus suis infection
PCT/EP2015/061961 WO2015181356A1 (en) 2014-05-30 2015-05-29 Vaccine composition against streptococcus suis infection

Publications (1)

Publication Number Publication Date
DK3148576T3 true DK3148576T3 (da) 2021-01-18

Family

ID=50846835

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15726586.9T DK3148576T3 (da) 2014-05-30 2015-05-29 Vaccinesammensætning mod streptococcus suis-infektion

Country Status (20)

Country Link
US (3) US20170209561A1 (da)
EP (3) EP2949340A1 (da)
JP (2) JP6670304B2 (da)
KR (1) KR102480824B1 (da)
CN (2) CN106561082B (da)
AU (1) AU2015265884B2 (da)
BR (1) BR112016028066A2 (da)
CA (1) CA2947798A1 (da)
DE (1) DE202015009979U1 (da)
DK (1) DK3148576T3 (da)
ES (1) ES2846698T3 (da)
HU (1) HUE053084T2 (da)
MX (1) MX2016015821A (da)
MY (1) MY178365A (da)
NZ (1) NZ726364A (da)
PL (1) PL3148576T3 (da)
PT (1) PT3148576T (da)
RU (1) RU2735101C2 (da)
WO (1) WO2015181356A1 (da)
ZA (1) ZA201607627B (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2949340A1 (en) 2014-05-30 2015-12-02 IDT Biologika GmbH Vaccine composition against Streptococcus suis infection
US11155585B2 (en) * 2015-07-09 2021-10-26 Intervacc Ab Vaccine against S. suis infection
WO2018175783A1 (en) * 2017-03-22 2018-09-27 Modernatx, Inc. Rna bacterial vaccines
RU2769573C2 (ru) * 2017-08-03 2022-04-04 Интервет Интернэшнл Б.В. Вакцина для защиты от streptococcus suis
US10968258B2 (en) 2017-08-31 2021-04-06 Boehringer Ingelheim Animal Health USA Inc. Streptococcus suis vaccines to protect against reproductive, nursery-age, and growing pig diseases and methods of making and use thereof
US20220339276A1 (en) * 2017-12-15 2022-10-27 Intervet Inc. A vaccine for protection against streptococcus suis
US11103569B2 (en) 2017-12-15 2021-08-31 Intervet Inc. Vaccine for protection against Streptococcus suis
CA3083977A1 (en) * 2017-12-15 2019-06-20 Intervet International B.V. A vaccine for protection against streptococcus suis
EP3549600A1 (en) * 2018-04-03 2019-10-09 Intervet International B.V. A vaccine for protection against streptococcus suis
KR102073086B1 (ko) * 2018-06-04 2020-02-04 (주)인트론바이오테크놀로지 신규한 스트렙토코커스 수이스 박테리오파지 Str-SUP-1 및 이의 스트렙토코커스 수이스 균 증식 억제 용도
JP7295223B2 (ja) * 2018-08-27 2023-06-20 インターベット インターナショナル ベー． フェー． 混合ワクチン
US11696944B2 (en) 2018-11-08 2023-07-11 Intervet Inc. Vaccine for protection against Streptococcus suis
ES2937136T3 (es) 2018-11-23 2023-03-24 Intervet Int Bv Vacuna de antígeno de proteasa IgM para proteger contra Streptococcus suis
KR102524577B1 (ko) * 2019-04-22 2023-04-21 전남대학교산학협력단 플라젤린 융합 단백질 및 이의 용도
WO2021073778A1 (en) 2019-10-14 2021-04-22 Ceva Sante Animale Compositions and methods for vaccinating piglets against streptococcus
US20220378900A1 (en) 2019-11-20 2022-12-01 Intervet Inc. A novel vaccine against heamophilus parasuis
WO2021099446A1 (en) 2019-11-20 2021-05-27 Intervet International B.V. A novel vaccine against heamophilus parasuis
JP2023503057A (ja) 2019-11-20 2023-01-26 インターベット インターナショナル ベー． フェー． ヘモフィルス・パラスイスに対する新規ワクチン
JP2023517684A (ja) 2020-03-14 2023-04-26 インターベット インターナショナル ベー． フェー． ストレプトコッカス・スイス血清型９、配列型１６に対する防御のためのワクチン
CN112410310A (zh) * 2020-10-28 2021-02-26 天津农学院 一种猪链球菌疫苗重组蛋白gse及其制备方法和应用
CN113444694B (zh) * 2021-06-22 2022-09-30 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 马链球菌马亚种噬菌体sp2019-lx株及其在制备腺疫治疗性药物中的应用
CN113332421B (zh) * 2021-07-02 2022-07-19 江苏省农业科学院 一种猪链球菌病疫苗
US20240335520A1 (en) 2021-08-03 2024-10-10 Intervet Inc. A vaccine for protection against streptococcus suis of various serotypes
CN117794565A (zh) 2021-08-03 2024-03-29 英特维特国际股份有限公司 用于保护以对抗多种血清型的猪链球菌的疫苗
JP2024528169A (ja) 2021-08-03 2024-07-26 インターベット インターナショナル ベー． フェー． 様々な血清型のストレプトコッカス・スイスに対する防御のためのワクチン
WO2023088988A1 (en) 2021-11-18 2023-05-25 Intervet International B.V. A method to produce a vaccine against streptococcus suis and the said vaccine
WO2023203238A1 (en) * 2022-04-22 2023-10-26 Intervacc Ab Streptococcus suis vaccine composition comprising immunogenic fusion polypeptides
US12091694B2 (en) 2022-11-18 2024-09-17 Seismic Therapeutic, Inc. Fc fusion molecules and uses thereof
WO2024112492A1 (en) * 2022-11-22 2024-05-30 Duke University Compositions comprising antibody cleaving enzymes and method of using the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA97452B (en) * 1996-01-25 1997-08-15 Trinity College Dublin Streptococcus equi vaccine.
HU228497B1 (en) * 1998-02-20 2013-03-28 Id Biomedical Corp Quebec Group b steptococcus antigens
MXPA03009294A (es) * 2001-04-13 2004-04-20 Wyeth Corp Proteinas de superficie de streptococcus pyogenes.
DE10239629A1 (de) * 2002-08-23 2004-04-08 Idt Impfstoffwerk Dessau-Tornau Gmbh Nicht-rekombinate Subunit-Vakzine gegen Streptococcus suis-Infektionen des Schweines
EP1943342B1 (en) * 2005-09-02 2016-04-13 Valorisation-Recherche, Limited Partnership Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications
EP2227249B1 (en) * 2007-12-13 2018-04-25 Intervacc AB Improved immunizing composition
TW201043242A (en) * 2009-03-26 2010-12-16 Intervet Int Bv Vaccine for protection against Streptococcus suis bacteria of various serotypes
EP3135684B1 (en) * 2010-05-26 2023-06-28 Intervacc AB Vaccine against streptococcal infections based on recombinant fusion proteins
EP2949340A1 (en) 2014-05-30 2015-12-02 IDT Biologika GmbH Vaccine composition against Streptococcus suis infection
CA3083977A1 (en) 2017-12-15 2019-06-20 Intervet International B.V. A vaccine for protection against streptococcus suis

Also Published As

Publication number Publication date
NZ726364A (en) 2023-05-26
US12036275B2 (en) 2024-07-16
ZA201607627B (en) 2020-09-30
JP2020019816A (ja) 2020-02-06
KR20170005855A (ko) 2017-01-16
RU2735101C2 (ru) 2020-10-28
PL3148576T3 (pl) 2021-05-04
HUE053084T2 (hu) 2021-06-28
CN113769076A (zh) 2021-12-10
JP6909268B2 (ja) 2021-07-28
EP3148576B1 (en) 2020-10-28
US20170209561A1 (en) 2017-07-27
RU2016146801A3 (da) 2018-12-10
KR102480824B1 (ko) 2022-12-22
WO2015181356A1 (en) 2015-12-03
AU2015265884A1 (en) 2016-12-08
US20220401543A1 (en) 2022-12-22
RU2016146801A (ru) 2018-05-29
MY178365A (en) 2020-10-09
ES2846698T3 (es) 2021-07-28
WO2015181356A8 (en) 2016-12-22
CN106561082B (zh) 2021-08-03
CN106561082A (zh) 2017-04-12
PT3148576T (pt) 2021-02-01
JP2017518367A (ja) 2017-07-06
CA2947798A1 (en) 2015-12-03
AU2015265884B2 (en) 2021-03-04
EP2949340A1 (en) 2015-12-02
US20210015910A1 (en) 2021-01-21
JP6670304B2 (ja) 2020-03-18
EP3148576A1 (en) 2017-04-05
EP3148576B8 (en) 2020-12-30
EP3795174A1 (en) 2021-03-24
BR112016028066A2 (pt) 2017-10-24
MX2016015821A (es) 2017-04-25
DE202015009979U1 (de) 2022-05-23

Similar Documents

Publication Publication Date Title
DK3148576T3 (da) Vaccinesammensætning mod streptococcus suis-infektion
DK3393510T5 (da) Zikavirusvaccine
DK3319633T3 (da) Vaccine mod rsv
DK3360558T3 (da) Sammensætninger omfattende bakteriestammer
DK3369425T3 (da) Sammensætninger omfattende bakteriestammer
DK3650033T3 (da) Sammensætninger omfattende bakteriestammer
DK3116994T3 (da) Phage-ufølsom streptococcus thermophilus
DK3151672T3 (da) Forbedrede t-celle-sammensætninger
DK3104718T3 (da) Tobaksholdig gelsammensætning
DK3129007T3 (da) Vaccinesammensætninger
BR112018004817A2 (pt) Amortecedor
DK3303357T3 (da) Vacciner mod streptococcus pneumoniae serotype 5
DK3126391T3 (da) ANTISTOFFER MOD HPA-1a
KR20180084993A (ko) 회전 변위 장치
DK3542819T3 (da) Hidtil ukendte vaccinesammensætninger omfattende immunstimulerende oligonukleotider
DK3139745T3 (da) Vacciner mod genital herpes-simplex-infektioner
KR20180084728A (ko) 구강용 조성물
DK3359102T3 (da) Medicinsk plaster
DE112016001834A5 (de) Kanüle
FR3019000B1 (fr) Composition de clomazone, sa preparation et son utilisation
BR112016025083A2 (pt) implemento de cuidado oral
IT201600120697A1 (it) Dispositivi di azionamento per strumenti di pozzo
DK3325015T3 (da) Liposomale adjuvanssammensætninger
DK3193923T3 (da) Adjuvanser
BR112017012631A2 (pt) formulações de antisséptico bucal